Joachim Koch

Joachim Koch

Company: Affimed GmbH

Job title: Head of Translational Research & Innovation


Affimed’s Bispecific Innate Cell Engagers: Activating CD16A for Tumor Cell Killing 10:15 am

• Deep dive into Affimed’s ROCK® platform allows development of high affinity Innate Cell Engagers that activate all variants of CD16A • Learn how innate cell engagers can be designed to target a multitude of tumor antigens • Examine how clinical data have shown early signs of efficacy and a promising safety profile for Affimed’s…Read more

day: Pre-Conference Focus Day

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.